Carnival Corporation
CCL
$25.88
+8.01%
Carnival Corporation is the world's largest global cruise company, operating a fleet of over 90 ships across a portfolio of well-known brands. Its identity is defined by its dominant market position and scale advantages in the leisure and travel industry.
CCL
Carnival Corporation
$25.88
Related headlines
Investment Opinion: Should I buy CCL Today?
Based on a synthesis of the data, the objective assessment leans towards a 'Hold' rating for risk-averse investors and a speculative 'Buy' for deep-value, high-risk-tolerance investors. The compelling valuation (Forward P/E of 9.1, PEG of 0.31) and strong free cash flow generation are positive, but they are counterbalanced by severe technical damage, high financial leverage, and earnings volatility. The positive analyst consensus suggests underlying value, but immediate catalysts are needed to reverse the powerful downtrend. This is not personalized financial advice but an assessment of the conflicting data points.
Sign up to view all
CCL 12-Month Price Forecast
The analysis reveals a stark conflict: the stock is fundamentally cheap with strong cash generation but is technically broken and carries substantial balance sheet risk. The near-term path is highly dependent on oil prices and macroeconomic sentiment, leading to a neutral stance with medium confidence due to these opposing forces.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Carnival Corporation's 12-month outlook, with a consensus price target around $33.64 and implied upside of +30.0% versus the current price.
Average Target
$33.64
10 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
10
covering this stock
Price Range
$21 - $34
Analyst target range
Wall Street analyst coverage for Carnival is active, with 10 analysts providing estimates. The consensus estimated EPS for the coming period is $4.04, with a range from $3.97 to $4.13. Estimated average revenue is $32.32 billion. Recent institutional ratings from firms like Mizuho, Barclays, Morgan Stanley, Goldman Sachs, and Wells Fargo are generally positive, with actions such as 'Outperform', 'Overweight', and 'Buy'.
Bulls vs Bears: CCL Investment Factors
Carnival presents a classic value vs. risk dichotomy. Its strong cash flow, improving margins, and low valuation multiples are offset by a weak balance sheet, extreme stock price volatility, and high sensitivity to macroeconomic shocks. The stock is in a pronounced bearish technical phase despite positive long-term fundamentals.
Bullish
- Strong Free Cash Flow: Generated $2.99B TTM FCF, indicating solid operational cash generation.
- Attractive Valuation Multiples: Forward P/E of 9.1 and PEG of 0.31 suggest potential undervaluation.
- Positive Analyst Sentiment: Consensus ratings are positive (Outperform, Overweight, Buy).
- Improving Profitability Metrics: ROE of 22.5% and Q1 gross margin of 36.1% show recovery.
Bearish
- Severe Technical Downtrend: Stock down 24% in 1 month, underperforming market by over 16%.
- Weak Balance Sheet Health: High debt-to-equity of 2.28 and concerning current ratio of 0.32.
- Volatile Quarterly Earnings: EPS fluctuated from $1.41 to $0.19, showing inconsistent profitability.
- High Sensitivity to Oil Prices: Recent news highlights vulnerability to crude oil price surges.
CCL Technical Analysis
The stock has experienced a significant downtrend over the past six months, with a price decline of 15.5%. This weakness has accelerated recently, with the stock down 24.1% over the past month and 22.3% over the past three months, significantly underperforming the broader market as indicated by negative relative strength figures of -16.2 and -14.9, respectively. Short-term performance has been extremely weak, with the price falling from around $32.70 in late February to $23.96 by March 30th. This represents a sharp correction from the higher levels seen in January and February, erasing most of the gains from the late 2025 rally. The current price of $23.96 sits near the lower end of its 52-week range of $15.07 to $34.03, representing a decline of approximately 30% from its yearly high. The stock is currently in a pronounced bearish phase, having broken below several key support levels during March.
Beta
2.46
2.46x market volatility
Max Drawdown
-31.9%
Largest decline past year
52-Week Range
$15-$34
Price range past year
Annual Return
+32.5%
Cumulative gain past year
| Period | CCL Return | S&P 500 |
|---|---|---|
| 1m | -18.0% | -5.3% |
| 3m | -15.3% | -4.6% |
| 6m | -10.3% | -2.8% |
| 1y | +32.5% | +15.9% |
| ytd | -16.3% | -4.6% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
CCL Fundamental Analysis
Revenue for the latest quarter (Q1 2026) was $6.17 billion, showing a year-over-year growth of 6.1%. However, profitability has been volatile; the net margin for Q1 2026 was 4.2%, a significant improvement from a net loss in Q1 2025, but down from the stronger 22.7% net margin achieved in Q3 2025. The quarterly EPS has fluctuated from $1.41 in Q3 2025 to $0.19 in the most recent quarter. Financial health is a concern, with a high debt-to-equity ratio of 2.28 and a weak current ratio of 0.32, indicating potential liquidity strain. Positively, the company generated $1.26 billion in operating cash flow and $697 million in free cash flow in Q1 2026, and has a trailing twelve-month free cash flow of $2.99 billion. Operational efficiency metrics show improvement, with a Return on Equity (ROE) of 22.5% and a Return on Assets (ROA) of 5.5% as of the latest data. The gross margin for Q1 2026 was 36.1%, up from 26.7% in the prior quarter, suggesting some recovery in pricing power or cost management.
Quarterly Revenue
$6.2B
2026-02
Revenue YoY Growth
+0.06%
YoY Comparison
Gross Margin
+0.36%
Latest Quarter
Free Cash Flow
$3.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is CCL Overvalued?
Since the company is profitable (Net Income > 0), the primary valuation metric is the Price-to-Earnings (P/E) ratio. The trailing P/E ratio is 12.3, and the forward P/E is 9.1 based on estimated EPS of $4.04. The PEG ratio is 0.31, suggesting the stock may be undervalued relative to its earnings growth expectations. Peer comparison data is not available in the provided inputs. Other valuation metrics include a Price-to-Sales ratio of 1.28, an EV/EBITDA of 8.69, and a Price-to-Book ratio of 2.77. The valuation appears modest based on earnings multiples, but the high debt load is reflected in the enterprise value metrics.
PE
12.3x
Latest Quarter
vs. Historical
High-End
5-Year PE Range -100x~52x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
8.7x
Enterprise Value Multiple
Investment Risk Disclosure
The primary risk is financial, stemming from a highly leveraged balance sheet with a debt-to-equity ratio of 2.28 and a current ratio of 0.32, indicating potential liquidity strain. This makes the company vulnerable to rising interest rates or a downturn in demand. Operational risks are significant, as evidenced by volatile quarterly earnings (Q1 2026 EPS of $0.19 vs. Q3 2025 EPS of $1.41) and high exposure to fuel costs, with recent news citing oil price surges above $110 as a direct headwind. Furthermore, the stock exhibits high systematic risk with a beta of 2.46, meaning it is more than twice as volatile as the broader market, which is confirmed by its severe underperformance (-24% vs. -7.9% for SPY) over the past month amid geopolitical tensions. The combination of financial fragility and cyclical sensitivity creates a material risk profile.
FAQ
The key risks are financial and operational. Financially, the company has a high debt-to-equity ratio of 2.28 and a weak current ratio of 0.32, indicating liquidity concerns. Operationally, earnings are volatile (Q1 EPS $0.19 vs. Q3 EPS $1.41), and the business is highly sensitive to oil price spikes, as recent news highlights. The stock's beta of 2.46 also signifies high market volatility.
The 12-month outlook is mixed with a base case target range of $26 to $32, representing a potential recovery from the current ~$24 price. This assumes the company meets the analyst consensus EPS estimate of $4.04. The bull case ($34-$38) depends on geopolitical relief and strong execution, while the bear case ($15-$22) involves a retest of 52-week lows if macro risks intensify.
Based on earnings multiples, CCL appears undervalued. Its trailing P/E is 12.3, and its forward P/E is 9.1, which is low for a company with analyst-estimated EPS growth. The PEG ratio of 0.31 (below 1.0) is a classic sign of undervaluation. However, this cheap valuation is offset by balance sheet risks, as reflected in its high EV/EBITDA of 8.7.
CCL is a speculative buy for investors with high risk tolerance. Its forward P/E of 9.1 and PEG ratio of 0.31 suggest significant undervaluation relative to growth expectations, and it generates strong free cash flow. However, the stock is in a severe downtrend, down 24% in a month, and carries a high debt load (Debt/Equity of 2.28), making it unsuitable for conservative portfolios.
CCL is more suitable for a long-term, patient investment horizon. The short-term is dominated by technical weakness and macro sentiment, making timing difficult. Long-term investors can potentially benefit from the cyclical recovery of travel, the company's dominant market position, and its low valuation, provided they can withstand significant interim volatility and the company successfully manages its debt.